×

Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing

  • US 6,387,403 B1
  • Filed: 09/14/2000
  • Issued: 05/14/2002
  • Est. Priority Date: 09/15/1999
  • Status: Expired due to Term
First Claim
Patent Images

1. An osmotic dosage form adapted to release reboxetine at a uniform rate comprising:

  • a. a semipermeable membrane defining an internal compartment;

    b. an osmotic composition component comprising reboxetine and a carbohydrate within the internal compartment; and

    c. a delivery orifice formed or formable in the semipermeable membrane through which the reboxetine is delivered.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×